A study by Fontana et al. [48] demonstrated that agonist-stimulated production of interferon-γ (IFN-gamma) and macrophage chemoattractant protein-1 (MCP-1) are significantly suppressed in subjects with obesity. Here, IFNG is linked to obesity disorder.